Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
The days of chemotherapy as the default cancer treatment method could soon be over, as recent breakthroughs in molecularly targeted therapies — which shut down the processes that help cancer form — show great leaps in clinical trials. Chemotherapy has proven itself successful over the last two decades, as cancer rates have dropped by 20 percent in the U.S., but its carpet-bombing method of cancer cell destruction often afflicts healthy cells in the process. Patients undergoing targeted treatments can experience less severe side effects and better survival rates due to the method’s “smart bomb” capabilities of destroying harmful cancer cells while leaving healthy cells untouched.
Hey, check out all the research scientist jobs. Post your resume today!
